This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.

The Epoch Times
The Epoch Times
Focus

Guillain-Barré syndrome

LATEST

COVID Vaccines
COVID Vaccines
|
Ellen Wan

Certain COVID-19 Vaccines Linked to Elevated Risk of Guillain-Barré Syndrome

As the rate of vaccination increases so has the incidence of GBS—particularly after viral vector-based vaccines such as AstraZeneca.

Nov 09, 2023
|
Ellen Wan
Certain COVID-19 Vaccines Linked to Elevated Risk of Guillain-Barré Syndrome
Nov 09
|
Frontline Health
Frontline Health
|
Dan Skorbach

Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver

Jul 22, 2023
|
Dan Skorbach
Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver
Jul 22
|
COVID News
COVID News
|
Zachary Stieber

Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study

Feb 03, 2023
|
Zachary Stieber
Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study
Feb 03
|
Canada
Canada
|
Lee Harding

COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured

Jun 03, 2022
|
Lee Harding
COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured
Jun 03
|
Vaccines & Safety
Vaccines & Safety
|
Marina Zhang

‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine

May 31, 2022
|
Marina Zhang
‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
May 31
|
Vaccines & Safety
Vaccines & Safety
|
Jack Phillips

Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU

Sep 08, 2021
|
Jack Phillips
Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU
Sep 08
|
COVID Vaccines
COVID Vaccines
|
Meiling Lee

Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel

Jul 22, 2021
|
Meiling Lee
Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel
Jul 22
|
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.